<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03892460</url>
  </required_header>
  <id_info>
    <org_study_id>17-0413</org_study_id>
    <nct_id>NCT03892460</nct_id>
  </id_info>
  <brief_title>Transitional Rehabilitation in CABG Patients</brief_title>
  <official_title>Novel Transitional Rehabilitation Care in Coronary Artery Bypass Graft Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research study is to understand whether an at-home exercise program started
      soon after CABG surgery, and continuing for 4 weeks following discharge from the hospital,
      can preserve or improve physical function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery bypass graft (CABG) surgery is a common surgical procedures and an important
      treatment option for coronary artery disease. The post-surgery period of rest and recovery is
      associated with cardiorespiratory and skeletal muscle deconditioning. The goal of this
      research study is to understand whether an at-home exercise program started soon after CABG
      surgery, and continuing for 4 weeks following discharge from the hospital, can serve as a
      bridge between surgery and the start of cardiac rehabilitation to preserve or improve
      physical function. Volunteers will be randomly assigned to receive neuromuscular electrical
      stimulation (NMES) of their quadriceps muscles or not to receive NMES (control group).
      Volunteers will be evaluated prior to CABG, upon discharge and 4 weeks Post-CABG surgery.
      Assessments will include measurements of physical function by the Short Physical Performance
      Battery, 6 min walk tests and body composition analysis, as well as assessment of subjective
      physical functional capacity and quality of life using the Medical Outcomes Short form 36.
      Additionally, accelerometry will be used to monitor weight-bearing physical activity during
      the 4 week treatment phase.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">October 24, 2019</completion_date>
  <primary_completion_date type="Actual">October 24, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short physical performance battery</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minute walk distance</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Artery Bypass Graft Surgery</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromuscular electrical stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No treatment control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>neuromuscular electrical stimulation</intervention_name>
    <description>bilateral quadriceps exercise with neuromuscular electrical stimulation</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-80 yrs of age

          -  ambulatory

          -  scheduled for coronary artery bypass graft surgery

          -  able to provide informed consent

        Exclusion Criteria:

          -  rheumatoid arthritis or other inflammatory/autoimmune disease

          -  cancer, excluding non-melanoma skin cancer

          -  exercise limiting peripheral vascular disease

          -  neuromuscular disease or neuromuscular dysfunction associated with cerebrovascular
             event

          -  body mass index &gt;38 kg/m2

          -  valvular heart disease not corrected surgically

          -  lower extremity blood clot or implantable cardioverter-defibrillator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Vermont College of Medicine</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Michael J. Toth, Ph.D.</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

